On classification approaches, terminology and modern principles of treatment of pathologies associated with high myopia. Part 3. Approaches to monitoring and treatment of patients
V. V. Neroev,
O. V. Zaytseva,
E. P. Tarutta,
E. V. Bobykin,
M. A. Kovalevskaya,
R. R. Fayzrakhmanov,
P. A. Nechiporenko https://doi.org/10.21516/2072-0076-2023-16-1-supplement-23-39
Abstract
High myopia is a common ametropia associated with a significant risk of multiple comorbidities. Decreased visual functions of myopic patients may be caused by non-specific diseases such as cataracts, glaucoma and rhegmatogenous retinal detachment, which are very likely in myopia. Yet especially important are the specific changes such as atrophic, traction and neovascular manifestations of pathological myopia, the totality of which is defined as myopic macular degeneration or myopic maculopathy. The review highlights current approaches to the diagnosis and treatment of various diseases associated with high myopia, including original schemes for managing patients with myopic choroidal neovascularization and myopic traction maculopathy, developed by experts from the Expert Council on Retinal and Optic Nerve Diseases of the Russian nationwide public body Association of ophthalmologists, and includes an information leaflet for patients.
About the Authors
V. V. Neroev
Helmholtz National Medical Research Center of Eye Diseases; A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Vladimir V. Neroev — Academician of RAS, Dr. of Med. Sci., professor, director, head of eye diseases chair of the faculty of additional professional education
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
20, p.1, Delegatskaya St., Moscow, 127473
O. V. Zaytseva
Helmholtz National Medical Research Center of Eye Diseases; A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Ol'ga V. Zaytseva — Cand. of Med. Sci., deputy director, leading researcher of the department of retina and optic nerve pathology, assistant professor of the department of eye diseases of the faculty of additional professional education
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
20, p.1, Delegatskaya St., Moscow, 127473
E. P. Tarutta
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Elena P. Tarutta — Dr. of Med. Sci., professor, head of the department of refraction pathology, binocular vision and ophthalmoergonomics
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
E. V. Bobykin
Ural State Medical University
Russian Federation
Russian Federation
Evgeny V. Bobykin — Dr. of Med. Sci., assistant professor of the department
of ophthalmology
3, Repin St., Yekaterinburg, 620028
M. A. Kovalevskaya
N.N. Burdenko Voronezh State Medical University
Russian Federation
Russian Federation
Maria A. Kovalevskaya — Dr. of Med. Sci., professor, head of ophthalmology chair
10, Studencheskaya St., Voronezh, 394036
R. R. Fayzrakhmanov
N.I. Pirogov National Medical and Surgical Center
Russian Federation
Russian Federation
Rinat R. Fayzrakhmanov — Dr. of Med Sci., professor, head of chair of
ophthalmology
70, Nizhnyaya Pervomayskaya St., Moscow, 105203
P. A. Nechiporenko
Academician I.P. Pavlov First St. Petersburg State Medical University
Russian Federation
Russian Federation
Pavel A. Nechiporenko — Cand. of Med. Sci., assistant professor of the clinical ophthalmology department n. a. professor Y.S. Astakhov
6-8, Lev Tolstoy St., 197022, St. Petersburg,
References
1. Нероев В.В., Зайцева О.В., Тарутта Е.П. и др. О классификационных подходах, терминологии и современных принципах лечения патологических изменений глаз, ассоциированных с близорукостью высокой степени. Часть 1. Критерии миопии высокой степени и патологической близорукости. Российский офтальмологический журнал. 2023; 16 (1 Приложение): 7-14. [Neroev V.V., Zaytseva O.V., Tarutta E.P., et al. On classification approaches, terminology and modern principles of treatment of pathologies associated with high myopia. Part 1. Criteria for high myopia and pathological myopia. Russian ophthalmological journal. 2023; 16 (1 Supplement): 7-14 (in Russian)]. https://doi.org/10.21516/2072-0076-2023-16-1-supplement-7-14
2. Нероев В.В., Зайцева О.В., Тарутта Е.П. и др. О классификационных подходах, терминологии и современных принципах лечения патологических изменений глаз, ассоциированных с близорукостью высокой степени. Часть 2. Терминология и подходы к классификации. Российский офтальмологический журнал. 2023; 16 (1 Приложение): 15-22. [Neroev V.V., Zaytseva O.V., Tarutta E.P., et al. On classification approaches, terminology and modern principles of treatment of pathologies associated with high myopia. Part 2. Terminology and approaches to classification. Russian ophthalmological journal. 2023; 16 (1 Supplement): 15-22 (in Russian)]. https://doi.org/10.21516/2072-0076-2023-16-1-supplement-15-22
3. EyeWiki, the Eye Encyclopedia. Pathologic Myopia (Myopic Degeneration). Available at: https://eyewiki.org/Pathologic_Myopia_(Myopic_Degeneration) (Accessed 14 Feb. 2023).
4. Peterson J., Dawoud S.A., Mortensen Z., Binkley E. Pathologic Myopia. EyeRounds.org. 2021; February 24. Available at: https://EyeRounds.org/cases/310-pathologic-myopia.htm (Accessed 09. Jan. 2023).
5. Ohno-Matsui K., Kawasaki R., Jonas J.B., et al. International photographic classification and grading system for myopic maculopathy. Am. J. Ophthalmol. 2015; 159 (5): 877–83. e7. https://doi.org/10.1016/j.ajo.2015.01.022
6. Verkicharla P.K., Ohno-Matsui K., Saw S.M. Current and predicted demographics of high myopia and an update of its associated pathological changes. Ophthalmic. Physiol. Opt. 2015; 35 (5): 465–75. https://doi.org/10.1111/opo.12238
7. Jonas J.B., Ang M., Cho P., et al. IMI Prevention of Myopia and Its Progression. Invest Ophthalmol Vis Sci. 2021; 62(5): 6. https://doi.org/10.1167/iovs.62.5.6
8. Государственный реестр лекарственных средств. Атропин. [State register of medicines. Atropine. (in Russian)]. Available at: https://grls.rosminzdrav.ru/GRLS.aspx?RegNumber=&MnnR=%d0%b0%d1%82%d1%80%d0%be%d0%bf%d0%b8%d0%bd&lf=&TradeNmR=&OwnerName=&MnfOrg=&MnfOrgCountry=&isfs=0&order=RegDate&orderType=desc&RegType=1%2c6&pageSize=10&pageNum=1
9. Иомдина Е.Н., Тарутта Е.П., Маркосян Г.А. и др. Современная оценка эффективности и безопасности склеропластики при прогрессирующей миопии. Российский офтальмологический журнал. 2021; 14 (1): 96–103. [Iomdina E.N., Tarutta E.P., Markosian G.A., et al. Current assessment results of the efficacy and safety of scleroplasty in progressive myopia. Russian Ophthalmological Journal. 2021; 14 (1): 96–103 (in Russian)]. https://doi.org/10.21516/2072-0076-2021-14-1-96-103
10. Тарутта Е.П., Иомдина Е.Н., Кружкова Г.В. и др. Отдаленные результаты склерореконструктивного лечения прогрессирующей миопии. Российский офтальмологический журнал. 2011; 4 (1): 71–5. [Tarutta E.P., Iomdina E.N., Kruzhkova G.V., et al. Long-term results of sclera reconstructive surgery of progressive myopia. Russian ophthalmological journal. 2011; 4 (1): 71–5 (in Russian)].
11. Миопия. Клинические рекомендации [Myopia. Clinical recommendations (in Russian)]. Available at: http://avo-portal.ru/doc/fkr/odobrennye-nps-iutverzhdennye-avo/item/257-miopiya
12. Huang W., Duan A., Qi Y. Posterior scleral reinforcement to prevent progression of high myopia. Asia Pac. J. Ophthalmol. (Phila). 2019; 8 (5): 366–70. https:// doi.org/10.1097/APO.0000000000000257
13. Kwok S.J.J., Forward S., Wertheimer C.M., et al. Selective Equatorial Sclera Crosslinking in the Orbit Using a Metal-Coated Polymer Waveguide. Invest Ophthalmol. Vis Sci. 2019; 60 (7): 2563–70. https://doi.org/10.1167/iovs.19-26709
14. Бобыкин Е.В., Морозова О.В., Береснева Н.С. Лечение заболеваний макулы: резюме ключевых рандомизированных клинических исследований. Российский офтальмологический журнал. 2021; 14 (4): 137–48. [Bobykin E.V., Morozova O.V., Beresneva N.S. Treatment of macular diseases: an overview of key randomized clinical trials. Russian ophthalmological journal. 2021; 14 (4): 137–48 (in Russian)]. https://doi.org/10.21516/2072-0076-2021-14-4-137-148
15. Onishi Y., Yokoi T., Kasahara K., et al. Five-year outcomes of intravitreal ranibizumab for choroidal neovascularization in patients with pathologic myopia. Retina. 2019; 39 (7): 1289–98. https://doi.org/10.1097/IAE.0000000000002164
16. Бобыкин Е.В. Режимы применения антиангиогенной терапии для лечения заболеваний макулы в офтальмологии. Обзор литературы. Практическая медицина. 2018; 16 (5): 104–11. [Bobykin E.V. Anti-angiogenic therapy for treatment of macular disorders in ophthalmology. Literature review. Practical Medicine. 2018; 16 (5): 104–11 (in Russian)].
17. Инструкция по медицинскому применению лекарственного препарата Луцентис. [Instructions for the medical use of the drug Lucentis (in Russian)]. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=0264cec1-448c-4ceb-8ce4-b0ae7702f557&t= (Accessed 14. Feb. 2023).
18. Инструкция по медицинскому применению лекарственного препарата Эйлеа. [Instructions for the medical use of the drug Eylea (in Russian)]. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=ee3a3a12-b52a-47f6-b35b-57c1d75c3d38&t= (Accessed 10. Feb. 2023).
19. Нероев В.В., Астахов Ю.С., Коротких С.А. и др. Протокол выполнения интравитреального введения лекарственных препаратов. Консенсус экспертного совета по заболеваниям сетчатки и зрительного нерва общероссийской общественной организации «Ассоциация врачей-офтальмологов». Вестник офтальмологии. 2020; 136 (6): 251–63. [Neroev V.V., Astakhov Yu.S. , Korotkih S.A., et al. Protocol of intravitreal drug delivery. Consensus of the Expert Counsil of Retina and Optic Nerve Diseases of the All-Russian Public Organasation “Association of Ophthalmologists”. Vestnik oftal’mologii. 2020; 136 (6): 251–63 (in Russian)]. https://doi.org/10.17116/oftalma2020136062251
20. Ohno-Matsui K., Ikuno Y., Lai T.Y.Y., Cheung C.M. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog Retin Eye Res. 2018; 63: 92–106. https://doi.org/10.1016/j.preteyeres.2017.10.005
21. Wong T.Y., Ohno-Matsui K., Leveziel N., et al. Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol. 2015; 99 (3): 289–96. https://doi.org/10.1136/bjophthalmol-2014-305131
22. Yana M., Onishi Y. Myopic macular neovascularization; treatment outcome (Including MP3). In: Ohno-Matsui K., eds Atlas of Pathologic Myopia. Singapore: Springer; 2020: 65–75. https://doi.org/10.1007/978-981-15-4261-9_12
23. Регматогенная отслойка сетчатки. Клинические рекомендации. [Rhegmatogenous retinal detachment. Clinical recommendations (in Russian)]. Available at: http://avo-portal.ru/doc/fkr/development/item/247-regmatogennaya-otsloyka-setchatki (Accessed 12. Feb. 2023).
24. Cicinelli M.V., La Franca L., De Felice E., et al. Long-term Incidence and risk factors of macular fibrosis, macular atrophy, and macular hole in eyes with myopic neovascularization. Ophthalmol Retina. 2022: 6 (12): 1231–40. https:// doi.org/10.1016/j.oret.2022.06.009 (Accessed 05. Dec. 2022).
25. Parolini B. Manage myopic traction maculopathy with ease. Available at: https://retinatoday.com/articles/2022-july-aug/manage-myopic-tractionmaculopathy-with-ease (Accessed 12. Feb. 2023).
26. Mahmoudzadeh R., Patel S.N., Wakabayashi T. How to manage pathologic myopia. Available at: https://www.reviewofophthalmology.com/article/howto-manage-pathologic-myopia (Accessed 12. Feb. 2023).
27. Ohno-Matsui K. Myopic macular retinoschisis. Pathologic myopia. https:// doi.org/10.1007/978-3-030-74334-5_20 Available at: https://link.springer.com/chapter/10.1007/978-3-030-74334-5_20 https://doi.org/10.1007/978-3-030-74334-5_20 (Accessed 09.Nov. 2022).
28. Omari A., Mahmoud T.H. Vitrectomy. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK551668/ (Accessed 22. Oct. 2022).
29. Parolini B., Palmieri M., Finzi A., Frisina R. Proposal for the management of myopic traction maculopathy based on the new MTM staging system. Eur J. Ophthalmol. 2021; 31 (6): 3265–76. https://doi.org/10.1177/1120672120980943 (Accessed 10. Feb. 2023).
30. Parolini B., Palmieri M., Finzi A., et al. The new myopic traction maculopathy staging system. Eur J. Ophthalmol. 2021; 31 (3): 1299–312. https://doi.org/10.1177/1120672120930590 (Accessed 04. Feb. 2023).
31. Катаракта старческая. Клинические рекомендации. [Cataract senile. Clinical recommendations (in Russian)]. Available at: http://avo-portal.ru/doc/fkr/odobrennye-nps-i-utverzhdennye-avo/item/256-katarakta-starcheskaya (Accessed 12. Feb. 2023).
32. Глаукома первичная открытоугольная. Клинические рекомендации. [Clinical recommendations (in Russian)]. Available at: http://avo-portal.ru/doc/fkr/odobrennye-nps-i-utverzhdennye-avo/item/246-glaukomaotkrytougolnaya (Accessed 21.Oct. 2022).
33. Периферические дегенерации сетчатки. Клинические рекомендации. [Peripheral retinal degeneration. Clinical recommendations (in Russian)]. Available at: http://avo-portal.ru/doc/fkr/approved/item/326-perifericheskiedegeneratsii-setchatki (Accessed 22.Oct. 2022).
34. Spaide R.F., Ohno-Matsui K. Myopic optic neuropathy. In: Spaide R.F., Ohno- Matsui K., Yannuzzi L.A., eds. Pathologic Myopia. Cham: Springer; 2021: 367. https://doi.org/10.1007/978-3-030-74334-5_25
35. Wilkinson C.P. Evidence-based analysis of prophylactic treatment of asymptomatic retinal breaks and lattice degeneration. Ophthalmology. 2000; 107 (1): 12–5; discussion 15–8. https://doi.org/10.1016/s0161-6420(99)00049-4
36. EyeWiki, the Eye Encyclopedia. Peripheral Retinal Degenerations. Available at: https://eyewiki.org/Peripheral_Retinal_Degenerations (Accessed 10. Feb. 2023).
37. Шаимова В.А., ред. Периферические дистрофии сетчатки. Оптическая когерентная томография. Лазерная коагуляция сетчатки: атлас. Санкт- Петербург: Человек; 2015. [Shaimova V.A., eds. Peripheral retinal dystrophies. Optical coherence tomography. Laser coagulation of the retina: atlas. Edited by. Saint-Petersburg: Chelovek; 2015 (in Russian)].
38. Neuhann I.M., Neuhann T.F., Heimann H., et al. Retinal detachment after phacoemulsification in high myopia: analysis of 2356 cases. J. Cataract Refract Surg. 2008; 34 (10): 1644–57. https://doi.org/10.1016/j.jcrs.2008.06.022
39. Dodick J.M., Kahn J.B. Special considerations for cataract surgery in the face of pathologic myopia. In: Spaide R.F., Ohno-Matsui K., Yannuzzi L.A., eds. Pathologic myopia. Cham; Springer; 2021: 389–97. https://doi.org/10.1007/978-3-030-74334-5_26
40. Нероев В.В., Коротких С.А., Бобыкин Е.В. и др. Информационный лифлет для пациентов, получающих лечение с применением интравитреального введения лекарственных препаратов. Рекомендации экспертного совета по заболеваниям сетчатки и зрительного нерва общероссийской общественной организации «Ассоциация врачей-офтальмологов». Российский офтальмологический журнал. 2021; 14 (2 Приложение): 7–19. [Neroev V.V., Korotkikh S.A., Bobykin E.V., et al. An information leaflet for patients receiving treatment by intravitreal drug injections. Recommendations of the Expert Council on retinal and optic nerve diseases of the Association of Ophthalmologists, an All-Russian public organization. Russian ophthalmological journal. 2021; 14 (2 Supplement): 7–19 (in Russian)]. https://doi.org/10.21516/2072-0076-2021-14-2-supplement-7-19 (Accessed 05. Dec. 2023).
41. Нероев В.В., Зайцева О.В., Бобыкин Е.В. и др. Результаты клинической апробации информационного лифлета для пациентов, получающих лечение интравитреальными инъекциями лекарственных препаратов. Российский офтальмологический журнал. 2021; 14 (2 Приложение): 20–8. [Neroev V.V., Zaytseva O.V., Bobykin E.V., et al. Results of clinical approbation of information leaflet for patients treated with intravitreal injections of drugs. Russian ophthalmological journal. 2021; 14 (2 Supplement): 20–8 (in Russian)]. https://doi.org/10.21516/2072-0076-2021-14-2-supplement-20-8
42. Оригинал-макет лифлета «Интравитреальные инъекции (информация для пациентов)». [The original layout of the leaflet “Intravitreal injections (information for patients)” (in Russian)]. Available at: http://avo-portal.ru/forpatients (Accessed 23. Sep. 2023).
43. Оригинал-макет лифлета «Патологическая миопия (информация для пациентов)». [The original layout of the leaflet “Pathological myopia (information for patients)” (in Russian)]. Available at: http://avo-portal.ru/forpatients
44. Chua J., Wong T.Y. Myopia-the silent epidemic thatshould not be ignored. JAMA Ophthalmol. 2016; 134 (12): 1363–4. https://doi.org/10.1001/jamaophthalmol.2016.4008
Review
For citations:
Neroev V.V., Zaytseva O.V., Tarutta E.P., Bobykin E.V., Kovalevskaya M.A., Fayzrakhmanov R.R., Nechiporenko P.A. On classification approaches, terminology and modern principles of treatment of pathologies associated with high myopia. Part 3. Approaches to monitoring and treatment of patients. Russian Ophthalmological Journal. 2023;16(1):24-32. (In Russ.) https://doi.org/10.21516/2072-0076-2023-16-1-supplement-23-39
Views:
501
Email this article 